HIV/AIDS
Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
Published in AIDS Weekly, September 1st, 2008
Vical Incorporated (NASDAQ:VICL) announced a research collaboration with the Karolinska Institute, a leading European medical university, and the Swedish Institute for Infectious Disease Control (SMI), a governmental expert agency, to evaluate Vical's Vaxfectin(R) adjuvant with the Biojector(R) 2000 needle-free injection system (Bioject Medical Technologies Inc., OTCBB:BJCT) for a multivalent preventive DNA vaccine against HIV.
Professor Eric Sandstrom, M.D., Ph.D., Professor at the Karolinska Institute, said, "The results from our initial Phase 1 trial were quite good, with over 90 percent of subjects achieving detectable immune responses against HIV after the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2008-09-01)
More Articles from AIDS Weekly
- Acidosis
Researchers at University of Oklahoma have published new data on acidosis - Falciparum Malaria
Recent findings from University of Oxford highlight research in falciparum malaria - HIV/AIDS
Research from National Institutes of Health has provided new data on HIV/AIDS - HIV/AIDS
Research reports on HIV/AIDS from Chung-Ang University, Medical Department provide new insights - HIV/AIDS
Researchers from Brigham and Women's Hospital describe findings in HIV/AIDS - HIV/AIDS
Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
